methylphenidate has been researched along with Hypertension in 25 studies
Methylphenidate: A central nervous system stimulant used most commonly in the treatment of ATTENTION DEFICIT DISORDER in children and for NARCOLEPSY. Its mechanisms appear to be similar to those of DEXTROAMPHETAMINE. The d-isomer of this drug is referred to as DEXMETHYLPHENIDATE HYDROCHLORIDE.
methylphenidate : A racemate comprising equimolar amounts of the two threo isomers of methyl phenyl(piperidin-2-yl)acetate. A central stimulant and indirect-acting sympathomimetic, is used (generally as the hydrochloride salt) in the treatment of hyperactivity disorders in children and for the treatment of narcolepsy.
methyl phenyl(piperidin-2-yl)acetate : A amino acid ester that is methyl phenylacetate in which one of the hydrogens alpha to the carbonyl group is replaced by a piperidin-2-yl group.
Hypertension: Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Methylphenidate did not increase 24-h heart rates, whereas omega-3 fatty acid supplementation significantly decreased elevated heart rates and increased HRV in adolescents with IST." | 1.56 | Diagnosis and management of an inappropriate sinus tachycardia in adolescence based upon a Holter ECG: A retrospective analysis of 479 patients. ( Baumann, C; Buchhorn, R; Gündogdu, S; Rakowski, U; Willaschek, C, 2020) |
| "OROS-methylphenidate was reported as the most helpful methylphenidate class formulation, with 74% reporting it at least somewhat helpful." | 1.39 | Caregiver survey of pharmacotherapy to treat attention deficit/hyperactivity disorder in individuals with Williams syndrome. ( Andridge, RR; Coury, DL; Foster, JE; Martens, MA; McClure, KE; Seyfer, DL, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 13 (52.00) | 18.7374 |
| 1990's | 1 (4.00) | 18.2507 |
| 2000's | 4 (16.00) | 29.6817 |
| 2010's | 5 (20.00) | 24.3611 |
| 2020's | 2 (8.00) | 2.80 |
| Authors | Studies |
|---|---|
| Buchhorn, R | 1 |
| Baumann, C | 1 |
| Gündogdu, S | 1 |
| Rakowski, U | 1 |
| Willaschek, C | 1 |
| Cortese, S | 1 |
| Espadas, M | 1 |
| Insa, I | 1 |
| Chamorro, M | 1 |
| Alda-Diez, JA | 1 |
| Dela Peña, I | 1 |
| Kim, BN | 1 |
| Han, DH | 1 |
| Kim, Y | 1 |
| Cheong, JH | 1 |
| Martens, MA | 1 |
| Seyfer, DL | 1 |
| Andridge, RR | 1 |
| Foster, JE | 1 |
| McClure, KE | 1 |
| Coury, DL | 1 |
| Fernández-Fernández, MA | 1 |
| Rufo-Campos, M | 1 |
| Mateos-Checa, R | 1 |
| Muñoz-Cabello, B | 1 |
| Madruga-Garrido, M | 1 |
| Blanco-Martínez, B | 1 |
| Mick, E | 1 |
| McGough, JJ | 1 |
| Middleton, FA | 1 |
| Neale, B | 1 |
| Faraone, SV | 1 |
| Klein-Schwartz, W | 1 |
| McGrath, J | 1 |
| Oster, MI | 1 |
| HEYDECKE, KH | 2 |
| CHRISTE, R | 2 |
| ACHOR, RW | 1 |
| BERGE, KG | 1 |
| SCHLEGEL, G | 1 |
| DAY, MD | 1 |
| RAND, MJ | 1 |
| RIU, J | 1 |
| Wilens, TE | 1 |
| Hammerness, PG | 1 |
| Biederman, J | 1 |
| Kwon, A | 1 |
| Spencer, TJ | 1 |
| Clark, S | 1 |
| Scott, M | 1 |
| Podolski, A | 1 |
| Ditterline, JW | 1 |
| Morris, MC | 1 |
| Moore, H | 1 |
| van den Bergh, FS | 1 |
| Bloemarts, E | 1 |
| Chan, JS | 1 |
| Groenink, L | 1 |
| Olivier, B | 1 |
| Oosting, RS | 1 |
| Deshmankar, BS | 1 |
| Lewis, JA | 1 |
| Blackman, JA | 1 |
| Samson-Fang, L | 1 |
| Gutgesell, H | 1 |
| Kudrin, AN | 1 |
| Davydova, ON | 1 |
| Krendal', FP | 1 |
| Brown, RT | 1 |
| Sexson, SB | 1 |
| Brichard, G | 1 |
| Guilleminault, C | 1 |
| Carskadon, M | 1 |
| Dement, WC | 1 |
| Fischer, KC | 1 |
| Wilson, WP | 1 |
| Meyer, JS | 1 |
| Eadie, GA | 1 |
| Ericsson, AD | 1 |
| Hoobler, SW | 1 |
| MacMahon, HR | 1 |
3 reviews available for methylphenidate and Hypertension
| Article | Year |
|---|---|
Pharmacologic Treatment of Attention Deficit-Hyperactivity Disorder.
Topics: Adolescent; Adult; Amphetamines; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperact | 2020 |
[Side effects of methylphenidate in children and the young].
Topics: Adolescent; Anorexia; Attention Deficit Disorder with Hyperactivity; Bone Diseases, Developmental; C | 2018 |
Abuse and dependence liability analysis of methylphenidate in the spontaneously hypertensive rat model of attention-deficit/hyperactivity disorder (ADHD): what have we learned?
Topics: Animals; Attention Deficit Disorder with Hyperactivity; Behavior, Addictive; Behavior, Animal; Blood | 2013 |
5 trials available for methylphenidate and Hypertension
| Article | Year |
|---|---|
Genome-wide association study of blood pressure response to methylphenidate treatment of attention-deficit/hyperactivity disorder.
Topics: Administration, Cutaneous; Attention Deficit Disorder with Hyperactivity; Blood Pressure; Central Ne | 2011 |
Blood pressure changes associated with medication treatment of adults with attention-deficit/hyperactivity disorder.
Topics: Adult; Amphetamines; Antidepressive Agents; Attention Deficit Disorder with Hyperactivity; Blood Pre | 2005 |
Effects of methylphenidate on cardiovascular responses in attention deficit hyperactivity disordered adolescents.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Black People; Blood Pressure; Child; Dose | 1989 |
[Practolol in anesthesia (ICI 50.172, Eraldin)].
Topics: Acetanilides; Adolescent; Adrenergic beta-Antagonists; Adult; Age Factors; Aged; Amino Alcohols; Ane | 1972 |
A pilot study of antihypertensive therapy in cerebrovascular disease.
Topics: Adult; Cerebrovascular Disorders; Clinical Trials as Topic; Depression; Female; Humans; Hypertension | 1967 |
17 other studies available for methylphenidate and Hypertension
| Article | Year |
|---|---|
Diagnosis and management of an inappropriate sinus tachycardia in adolescence based upon a Holter ECG: A retrospective analysis of 479 patients.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Electrocardiography, Ambulatory; Fatty Ac | 2020 |
Caregiver survey of pharmacotherapy to treat attention deficit/hyperactivity disorder in individuals with Williams syndrome.
Topics: Adolescent; Amphetamines; Aortic Stenosis, Subvalvular; Attention Deficit Disorder with Hyperactivit | 2013 |
[Cardiovascular side effects secondary to treatment with methylphenidate].
Topics: Central Nervous System Stimulants; Child; Humans; Hypertension; Male; Methylphenidate; Tachycardia | 2010 |
Poison centers' experience with methylphenidate abuse in pre-teens and adolescents.
Topics: Adolescent; Adult; Child; Female; Humans; Hypertension; Male; Methylphenidate; Poison Control Center | 2003 |
Efficacy or effectiveness: which comes first, the cure or the treatment?
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Humans | 2003 |
[Hypertension management in Los; experiences with serpatonil].
Topics: Disease Management; Hypertension; Methylphenidate; Reserpine | 1956 |
[Hypertension management in Los; experiences with serpatonil].
Topics: Disease Management; Hypertension; Methylphenidate; Reserpine | 1956 |
[Hypertension management in Los; experiences with serpatonil].
Topics: Disease Management; Hypertension; Methylphenidate; Reserpine | 1956 |
[Hypertension management in Los; experiences with serpatonil].
Topics: Disease Management; Hypertension; Methylphenidate; Reserpine | 1956 |
[Comparative therapeutic effect of serpasil-ritalin combination].
Topics: Hypertension; Methylphenidate; Reserpine | 1956 |
[Comparative therapeutic effect of serpasil-ritalin combination].
Topics: Hypertension; Methylphenidate; Reserpine | 1956 |
[Comparative therapeutic effect of serpasil-ritalin combination].
Topics: Hypertension; Methylphenidate; Reserpine | 1956 |
[Comparative therapeutic effect of serpasil-ritalin combination].
Topics: Hypertension; Methylphenidate; Reserpine | 1956 |
Treatment of hypertension using reserpine combined with a new analeptic agent, methyl-phenidylacetate hydrochloride; limitations of usefulness.
Topics: Central Nervous System Stimulants; Hypertension; Methylphenidate; Reserpine; Salts | 1957 |
[Ritalin, an adjuvant in the therapy of hypertension].
Topics: Adjuvants, Immunologic; Hypertension; Methylphenidate | 1958 |
Antagonism of guanethidine and bretylium by various agents.
Topics: Bretylium Compounds; Cocaine; Guanethidine; Hypertension; Methylphenidate; Monoamine Oxidase Inhibit | 1962 |
[Clinical experience with an association of reserpine and methylphenidylacetate].
Topics: Hypertension; Methylphenidate; Reserpine | 1959 |
Spontaneously hypertensive rats do not predict symptoms of attention-deficit hyperactivity disorder.
Topics: Age Factors; Animals; Attention Deficit Disorder with Hyperactivity; Behavior, Animal; Central Nervo | 2006 |
Ventricular tachycardia associated with the administration of methylphenidate during guanethidine therapy.
Topics: Drug Synergism; Electrocardiography; Guanethidine; Humans; Hypertension; Male; Methylphenidate; Midd | 1967 |
Clonidine and electrocardiograms.
Topics: Adult; Child; Clonidine; Drug Interactions; Electrocardiography; Humans; Hypertension; Methylphenida | 1996 |
[Pharmacologic incompatibility of neuroleptics and tranquilizers with other medicines].
Topics: Amphetamine; Animals; Anti-Anxiety Agents; Anti-Arrhythmia Agents; Anticonvulsants; Antipsychotic Ag | 1977 |
On the treatment of rapid eye movement narcolepsy.
Topics: Adult; Amphetamine; Antidepressive Agents; Cataplexy; Depression; Desipramine; Electroencephalograph | 1974 |
Methylphenidate and the hyperkinetic state.
Topics: Ataxia; Child; Drug Synergism; Feeding and Eating Disorders; Humans; Hyperkinesis; Hypertension; Met | 1971 |